AXA SA (AXA.DE) Stock Fundamental Analysis
Europe - FRA:AXA - FR0000120628 - Common Stock
40.05 EUR
+0.13 (+0.33%)
AXA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 42 industry peers in the Insurance industry. Both the profitability and the financial health of AXA get a neutral evaluation. Nothing too spectacular is happening here. AXA is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
AXA had positive earnings in the past year.
In the past year AXA had a positive cash flow from operations.
AXA had positive earnings in each of the past 5 years.
Each year in the past 5 years AXA had a positive operating cash flow.
1.2 Ratios
The Return On Assets of AXA (1.18%) is comparable to the rest of the industry.
AXA has a better Return On Equity (16.72%) than 64.29% of its industry peers.
AXA's Return On Invested Capital of 1.28% is in line compared to the rest of the industry. AXA outperforms 52.38% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AXA is in line with the industry average of 2.28%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.18% | ||
| ROE | 16.72% | ||
| ROIC | 1.28% |
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
1.3 Margins
AXA has a Profit Margin (8.52%) which is in line with its industry peers.
AXA's Profit Margin has improved in the last couple of years.
AXA has a Operating Margin (11.47%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of AXA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.47% | ||
| PM (TTM) | 8.52% | ||
| GM | N/A |
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AXA is destroying value.
Compared to 1 year ago, AXA has less shares outstanding
AXA has less shares outstanding than it did 5 years ago.
AXA has a worse debt/assets ratio than last year.
2.2 Solvency
AXA has an Altman-Z score of 0.35. This is a bad value and indicates that AXA is not financially healthy and even has some risk of bankruptcy.
With an excellent Altman-Z score value of 0.35, AXA belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
AXA has a debt to FCF ratio of 1.41. This is a very positive value and a sign of high solvency as it would only need 1.41 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 1.41, AXA is doing good in the industry, outperforming 78.57% of the companies in the same industry.
AXA has a Debt/Equity ratio of 0.65. This is a neutral value indicating AXA is somewhat dependend on debt financing.
AXA has a Debt to Equity ratio of 0.65. This is comparable to the rest of the industry: AXA outperforms 50.00% of its industry peers.
Even though the debt/equity ratio score it not favorable for AXA, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 1.41 | ||
| Altman-Z | 0.35 |
ROIC/WACC0.12
WACC10.69%
2.3 Liquidity
AXA has a Current Ratio of 0.82. This is a bad value and indicates that AXA is not financially healthy enough and could expect problems in meeting its short term obligations.
With an excellent Current ratio value of 0.82, AXA belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
A Quick Ratio of 0.82 indicates that AXA may have some problems paying its short term obligations.
AXA has a Quick ratio of 0.82. This is amongst the best in the industry. AXA outperforms 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 8.70% over the past year.
The Earnings Per Share has been growing by 18.09% on average over the past years. This is quite good.
The Revenue has been growing slightly by 4.40% in the past year.
Measured over the past years, AXA shows a decrease in Revenue. The Revenue has been decreasing by -8.16% on average per year.
EPS 1Y (TTM)8.7%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%8.56%
Revenue 1Y (TTM)4.4%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%3.72%
3.2 Future
The Earnings Per Share is expected to grow by 6.80% on average over the next years.
The Revenue is expected to grow by 8.27% on average over the next years. This is quite good.
EPS Next Y14.58%
EPS Next 2Y9.06%
EPS Next 3Y8.11%
EPS Next 5Y6.8%
Revenue Next Year8.83%
Revenue Next 2Y6.98%
Revenue Next 3Y7.01%
Revenue Next 5Y8.27%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.68, the valuation of AXA can be described as very reasonable.
73.81% of the companies in the same industry are more expensive than AXA, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.41, AXA is valued rather cheaply.
AXA is valuated reasonably with a Price/Forward Earnings ratio of 9.38.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AXA indicates a somewhat cheap valuation: AXA is cheaper than 73.81% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, AXA is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.68 | ||
| Fwd PE | 9.38 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AXA indicates a rather cheap valuation: AXA is cheaper than 80.95% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.15 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
AXA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.73
PEG (5Y)0.59
EPS Next 2Y9.06%
EPS Next 3Y8.11%
5. Dividend
5.1 Amount
AXA has a Yearly Dividend Yield of 5.43%, which is a nice return.
Compared to an average industry Dividend Yield of 4.63, AXA pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, AXA pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.43% |
5.2 History
The dividend of AXA is nicely growing with an annual growth rate of 8.12%!
Dividend Growth(5Y)8.12%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
AXA pays out 61.79% of its income as dividend. This is not a sustainable payout ratio.
The dividend of AXA is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP61.79%
EPS Next 2Y9.06%
EPS Next 3Y8.11%
FRA:AXA (9/22/2025, 7:00:00 PM)
40.05
+0.13 (+0.33%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners33.99%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap86.84B
Analysts81.48
Price Target45.42 (13.41%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.43% |
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP61.79%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.38%
PT rev (3m)3.58%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.7%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.58%
Revenue NY rev (3m)2.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.68 | ||
| Fwd PE | 9.38 | ||
| P/S | 0.97 | ||
| P/FCF | 4.15 | ||
| P/OCF | 4.06 | ||
| P/B | 1.91 | ||
| P/tB | 3.6 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.75
EY9.36%
EPS(NY)4.27
Fwd EY10.66%
FCF(TTM)9.65
FCFY24.1%
OCF(TTM)9.87
OCFY24.64%
SpS41.17
BVpS20.98
TBVpS11.12
PEG (NY)0.73
PEG (5Y)0.59
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.18% | ||
| ROE | 16.72% | ||
| ROCE | 1.62% | ||
| ROIC | 1.28% | ||
| ROICexc | 1.33% | ||
| ROICexgc | 1.74% | ||
| OM | 11.47% | ||
| PM (TTM) | 8.52% | ||
| GM | N/A | ||
| FCFM | 23.44% |
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexcg growth 3Y10.47%
ROICexcg growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 1.41 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.53% | ||
| Interest Coverage | 1.98 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 275.1% | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 0.35 |
F-Score7
WACC10.69%
ROIC/WACC0.12
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)8.7%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%8.56%
EPS Next Y14.58%
EPS Next 2Y9.06%
EPS Next 3Y8.11%
EPS Next 5Y6.8%
Revenue 1Y (TTM)4.4%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%3.72%
Revenue Next Year8.83%
Revenue Next 2Y6.98%
Revenue Next 3Y7.01%
Revenue Next 5Y8.27%
EBIT growth 1Y7.05%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year25.76%
EBIT Next 3Y11.02%
EBIT Next 5YN/A
FCF growth 1Y150.74%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y145.39%
OCF growth 3Y7.85%
OCF growth 5Y9.48%